Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

Halozyme Therapeutics, Inc. (HALO)

7.57 Up 0.02(0.26%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Key StatisticsGet Key Statistics for:
Data provided by Capital IQ, except where noted.
Valuation Measures 
Market Cap (intraday)5:862.22M
Enterprise Value (Apr 18, 2014)3:823.41M
Trailing P/E (ttm, intraday):N/A
Forward P/E (fye Dec 31, 2015)1:N/A
PEG Ratio (5 yr expected)1:N/A
Price/Sales (ttm):15.69
Price/Book (mrq):N/A
Enterprise Value/Revenue (ttm)3:15.03
Enterprise Value/EBITDA (ttm)6:-10.40
Financial Highlights 
Fiscal Year
Fiscal Year Ends:Dec 31
Most Recent Quarter (mrq):Dec 31, 2013
Profit Margin (ttm):-152.34%
Operating Margin (ttm):-146.78%
Management Effectiveness
Return on Assets (ttm):-42.51%
Return on Equity (ttm):-578.45%
Income Statement
Revenue (ttm):54.80M
Revenue Per Share (ttm):0.49
Qtrly Revenue Growth (yoy):-42.60%
Gross Profit (ttm):48.55M
EBITDA (ttm)6:-79.21M
Net Income Avl to Common (ttm):-83.48M
Diluted EPS (ttm):-0.74
Qtrly Earnings Growth (yoy):N/A
Balance Sheet
Total Cash (mrq):71.50M
Total Cash Per Share (mrq):0.63
Total Debt (mrq):49.77M
Total Debt/Equity (mrq):N/A
Current Ratio (mrq):3.74
Book Value Per Share (mrq):-0.18
Cash Flow Statement
Operating Cash Flow (ttm):-49.34M
Levered Free Cash Flow (ttm):-29.91M
View Financials
Income Statement - Balance Sheet - Cash Flow

Trading Information 
Stock Price History
52-Week Change3:36.15%
S&P500 52-Week Change3:20.97%
52-Week High (Jan 24, 2014)3:18.18
52-Week Low (Apr 18, 2013)3:5.47
50-Day Moving Average3:11.99
200-Day Moving Average3:13.33
Share Statistics
Avg Vol (3 month)3:2,398,730
Avg Vol (10 day)3:3,126,070
Shares Outstanding5:113.90M
% Held by Insiders1:3.88%
% Held by Institutions1:63.50%
Shares Short (as of Mar 31, 2014)3:13.07M
Short Ratio (as of Mar 31, 2014)3:6.40
Short % of Float (as of Mar 31, 2014)3:12.60%
Shares Short (prior month)3:13.09M
Dividends & Splits
Forward Annual Dividend Rate4:N/A
Forward Annual Dividend Yield4:N/A
Trailing Annual Dividend Yield3:N/A
Trailing Annual Dividend Yield3:N/A
5 Year Average Dividend Yield4:N/A
Payout Ratio4:N/A
Dividend Date3:N/A
Ex-Dividend Date4:N/A
Last Split Factor (new per old)2:N/A
Last Split Date3:N/A

See Key Statistics Help for definitions of terms used.
Abbreviation Guide: K = Thousands; M = Millions; B = Billions
mrq = Most Recent Quarter (as of Dec 31, 2013)
ttm = Trailing Twelve Months (as of Dec 31, 2013)
yoy = Year Over Year (as of Dec 31, 2013)
lfy = Last Fiscal Year (as of Dec 31, 2013)
fye = Fiscal Year Ending
1 Data provided by Thomson Reuters
2 Data provided by EDGAR Online
3 Data derived from multiple sources or calculated by Yahoo! Finance
4 Data provided by Morningstar, Inc.
5 Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.
6 EBITDA is calculated by Capital IQ using methodology that may differ from that used by a company in its reporting

Currency in USD.